Expired activity

Please go to the PowerPak homepage and select a course.

Respiratory Syncytial Virus in the Adult Population: Pharmacists’ and Pharmacy Technicians’ Important Roles in Promoting Prevention Through Vaccination

This activity is sponsored by Postgraduate Healthcare Education, LLC (PHE) and supported by an independent medical education grant from Pfizer Inc.

Registration INFORMATION

Tuesday, March 26, 2024
4:00 to 4:30 PM ET

Faculty

Kristy Brittain, PharmD
Professor, MUSC College of Pharmacy
Clinical Pharmacy and Outcome Sciences
Clinical Pharmacy Specialist, Medical University of South Carolina
Director, PGY-1 Community-Based Pharmacy Residency
Charleston, SC

Stacey Schneider, PharmD
Adjunct Professor
Clinical Psychopharmacology
Saybrook University
Pasadena, CA

ACCREDITATION STATEMENTS

PHARMACY
Postgraduate Healthcare Education, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Credits: 0.5 hours (0.05 ceu)
Estimated time to complete activity: 30 minutes

Location: From the convenience of your home or business; accessible via both PC and MAC
Fee Information: There is no fee. This is a free continuing education activity.
Type of Activity: Knowledge
Media: Internet

TARGET AUDIENCE

This activity has been designed to meet the needs of pharmacists and pharmacy technicians nationwide.

HOW TO EARN CREDIT

Participants must 1) read the learning objectives and faculty disclosures; 2) attend and participate in the live webinar; and 3) complete the post-test and evaluation form directly after the event with a maximum of within 60 days of attending the live session. To answer the questions, click on your selected choice for each answer then proceed to the next question. To receive Credit, you must provide your date of birth and NABP number. All Credit information will be uploaded into CPE monitor within 30 days.

Goal

The goal of this PowerUp Live Q&A session is to provide pharmacists and pharmacy technicians the opportunity to ask the faculty questions about promoting RSV prevention through vaccination.

For a more in-depth review of this topic, we recommend that you view the faculty’s CE monograph titled, Respiratory Syncytial Virus in the Adult Population: Pharmacists’ and Pharmacy Technicians’ Important Roles in Promoting Prevention Through Vaccination, available at www.powerpak.com/course/preamble/124507 (Pharmacists) and www.powerpak.com/course/preamble/124508 (Pharmacy Technicians). These activities expire on December 29, 2024.

LEARNING OBJECTIVES

At the conclusion of the activity, pharmacists and pharmacy technicians will be able to:

• Discuss the burden of disease of respiratory syncytial virus (RSV) on the older adult population and the benefits of prevention through vaccination
• Recognize available RSV vaccines and effective approaches to improve RSV vaccination rates for the older adult patient population

Agenda

Introduction (5 minutes)
Presentation (10 minutes)
Q&A (15 minutes)

REQUIRED COMPUTER HARDWARE/SOFTWARE

Please ensure the computer system you plan to use meets the following minimum requirements:

• Operating System: Windows 98 or higher & Macintosh 2.2 or higher
• Internet Browser (Mac & Windows): Internet Explorer 6.0 or higher, Google Chrome, Safari 5.0.6 or higher, Firefox 3.0.3 or higher, & Opera 5 or higher
• Broadband Internet connection: Cable, High-speed DSL & any other medium that is internet accessible
• Peripherals: Computer speakers or headphones
• Monitor Screen Resolution: 320 x 480 or higher
• Media Viewing Requirements: Adobe Reader, Microsoft PowerPoint, Flash Player & HTML5

Disclosure of Unlabeled Use and Disclaimer:

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Postgraduate Healthcare Education, LLC or Pfizer Inc. Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients' conditions, and possible contraindications on dangers in use, (review of any applicable manufacturer's product information) and comparison with recommendations of other authorities.

The author, sponsor, and publisher of this continuing education activity have made all reasonable efforts to ensure that all information contained herein is accurate in accordance with the latest available scientific knowledge at the time of acceptance for publication. However, because information regarding drugs (their administration, dosages, contraindications, adverse reactions, interactions, special warnings, precautions, etc.) is subject to constant change, the reader is advised to check the manufacturer's package insert for information concerning recommended dosages and potential problems and cautions prior to dispensing or administering the drug. Special precautions should be taken when a drug is new, or highly toxic, or is unfamiliar to the dispenser or administrant. This educational activity may contain discussion of published and/or investigational uses of agents that are not approved by the U.S. Food and Drug Administration (FDA). Neither the publisher nor sponsor promotes the use of any agent outside of approved labeling. Statements made in this activity have not been evaluated by the FDA.